IP Library › Patent Application 14795983
Patent Application
App. No. 14/795,983

METHOD OF TREATMENT OF CNS DISORDERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/795,983
Abstract

The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and μ-opioid agonistic activity.

Claims (3)

1 .- 9 . (canceled)

10 . A method of treating attention deficit hyperactivity disorder in a mammalian subject comprising administering to a subject in need thereof a total dose of 0.1 mg to 0.5 mg of mazindol per day as the sole active agent.

11 . The method of claim 10 , wherein the mammalian subject is orally administered mazindol.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 044552/0694 →